Global Human Vaccine Market Research Report 2024, Forecast to 2032
Report Overview
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global Human Vaccine market size was estimated at USD 31950 million in 2023 and is projected to reach USD 47891.23 million by 2032, exhibiting a CAGR of 4.60% during the forecast period.
North America Human Vaccine market size was estimated at USD 8994.71 million in 2023, at a CAGR of 3.94% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Human Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Vaccine market in any manner.
Global Human Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Market Segmentation (by Type)
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Market Segmentation (by Application)
Adults
Children
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global Human Vaccine market size was estimated at USD 31950 million in 2023 and is projected to reach USD 47891.23 million by 2032, exhibiting a CAGR of 4.60% during the forecast period.
North America Human Vaccine market size was estimated at USD 8994.71 million in 2023, at a CAGR of 3.94% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Human Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Vaccine market in any manner.
Global Human Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Indian Immunologicals
KANGH
Henan Grand Biopharma
ZhongKe Biopharm
Zhuoyi Biological
Market Segmentation (by Type)
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Market Segmentation (by Application)
Adults
Children
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Human Vaccine Market
- Overview of the regional outlook of the Human Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Human Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Human Vaccine
1.2 Key Market Segments
1.2.1 Human Vaccine Segment by Type
1.2.2 Human Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Human Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Vaccine Sales Sites, Area Served, Product Type
3.6 Human Vaccine Market Competitive Situation and Trends
3.6.1 Human Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Human Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Human Vaccine Price by Type (2019-2024)
7 HUMAN VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Vaccine Market Sales by Application (2019-2024)
7.3 Global Human Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Human Vaccine Sales Growth Rate by Application (2019-2024)
8 HUMAN VACCINE MARKET CONSUMPTION BY REGION
8.1 Global Human Vaccine Sales by Region
8.1.1 Global Human Vaccine Sales by Region
8.1.2 Global Human Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 HUMAN VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Human Vaccine by Region (2019-2024)
9.2 Global Human Vaccine Revenue Market Share by Region (2019-2024)
9.3 Global Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Human Vaccine Production
9.4.1 North America Human Vaccine Production Growth Rate (2019-2024)
9.4.2 North America Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Human Vaccine Production
9.5.1 Europe Human Vaccine Production Growth Rate (2019-2024)
9.5.2 Europe Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Human Vaccine Production (2019-2024)
9.6.1 Japan Human Vaccine Production Growth Rate (2019-2024)
9.6.2 Japan Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Human Vaccine Production (2019-2024)
9.7.1 China Human Vaccine Production Growth Rate (2019-2024)
9.7.2 China Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 CNBG
10.1.1 CNBG Human Vaccine Basic Information
10.1.2 CNBG Human Vaccine Product Overview
10.1.3 CNBG Human Vaccine Product Market Performance
10.1.4 CNBG Business Overview
10.1.5 CNBG Human Vaccine SWOT Analysis
10.1.6 CNBG Recent Developments
10.2 Changsheng Life
10.2.1 Changsheng Life Human Vaccine Basic Information
10.2.2 Changsheng Life Human Vaccine Product Overview
10.2.3 Changsheng Life Human Vaccine Product Market Performance
10.2.4 Changsheng Life Business Overview
10.2.5 Changsheng Life Human Vaccine SWOT Analysis
10.2.6 Changsheng Life Recent Developments
10.3 Zhifei
10.3.1 Zhifei Human Vaccine Basic Information
10.3.2 Zhifei Human Vaccine Product Overview
10.3.3 Zhifei Human Vaccine Product Market Performance
10.3.4 Zhifei Human Vaccine SWOT Analysis
10.3.5 Zhifei Business Overview
10.3.6 Zhifei Recent Developments
10.4 ChengDa Bio
10.4.1 ChengDa Bio Human Vaccine Basic Information
10.4.2 ChengDa Bio Human Vaccine Product Overview
10.4.3 ChengDa Bio Human Vaccine Product Market Performance
10.4.4 ChengDa Bio Business Overview
10.4.5 ChengDa Bio Recent Developments
10.5 Kangtai
10.5.1 Kangtai Human Vaccine Basic Information
10.5.2 Kangtai Human Vaccine Product Overview
10.5.3 Kangtai Human Vaccine Product Market Performance
10.5.4 Kangtai Business Overview
10.5.5 Kangtai Recent Developments
10.6 SINOVAC BIOTECH
10.6.1 SINOVAC BIOTECH Human Vaccine Basic Information
10.6.2 SINOVAC BIOTECH Human Vaccine Product Overview
10.6.3 SINOVAC BIOTECH Human Vaccine Product Market Performance
10.6.4 SINOVAC BIOTECH Business Overview
10.6.5 SINOVAC BIOTECH Recent Developments
10.7 Hissen
10.7.1 Hissen Human Vaccine Basic Information
10.7.2 Hissen Human Vaccine Product Overview
10.7.3 Hissen Human Vaccine Product Market Performance
10.7.4 Hissen Business Overview
10.7.5 Hissen Recent Developments
10.8 Walvax Biotechnology
10.8.1 Walvax Biotechnology Human Vaccine Basic Information
10.8.2 Walvax Biotechnology Human Vaccine Product Overview
10.8.3 Walvax Biotechnology Human Vaccine Product Market Performance
10.8.4 Walvax Biotechnology Business Overview
10.8.5 Walvax Biotechnology Recent Developments
10.9 GSK
10.9.1 GSK Human Vaccine Basic Information
10.9.2 GSK Human Vaccine Product Overview
10.9.3 GSK Human Vaccine Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 SANOFI
10.10.1 SANOFI Human Vaccine Basic Information
10.10.2 SANOFI Human Vaccine Product Overview
10.10.3 SANOFI Human Vaccine Product Market Performance
10.10.4 SANOFI Business Overview
10.10.5 SANOFI Recent Developments
10.11 Rong An
10.11.1 Rong An Human Vaccine Basic Information
10.11.2 Rong An Human Vaccine Product Overview
10.11.3 Rong An Human Vaccine Product Market Performance
10.11.4 Rong An Business Overview
10.11.5 Rong An Recent Developments
10.12 NuoCheng Bio
10.12.1 NuoCheng Bio Human Vaccine Basic Information
10.12.2 NuoCheng Bio Human Vaccine Product Overview
10.12.3 NuoCheng Bio Human Vaccine Product Market Performance
10.12.4 NuoCheng Bio Business Overview
10.12.5 NuoCheng Bio Recent Developments
10.13 Hualan Bio
10.13.1 Hualan Bio Human Vaccine Basic Information
10.13.2 Hualan Bio Human Vaccine Product Overview
10.13.3 Hualan Bio Human Vaccine Product Market Performance
10.13.4 Hualan Bio Business Overview
10.13.5 Hualan Bio Recent Developments
10.14 Tiantan biological
10.14.1 Tiantan biological Human Vaccine Basic Information
10.14.2 Tiantan biological Human Vaccine Product Overview
10.14.3 Tiantan biological Human Vaccine Product Market Performance
10.14.4 Tiantan biological Business Overview
10.14.5 Tiantan biological Recent Developments
10.15 Changchun Baike
10.15.1 Changchun Baike Human Vaccine Basic Information
10.15.2 Changchun Baike Human Vaccine Product Overview
10.15.3 Changchun Baike Human Vaccine Product Market Performance
10.15.4 Changchun Baike Business Overview
10.15.5 Changchun Baike Recent Developments
10.16 Adimmune
10.16.1 Adimmune Human Vaccine Basic Information
10.16.2 Adimmune Human Vaccine Product Overview
10.16.3 Adimmune Human Vaccine Product Market Performance
10.16.4 Adimmune Business Overview
10.16.5 Adimmune Recent Developments
10.17 Zhongyianke Biotech
10.17.1 Zhongyianke Biotech Human Vaccine Basic Information
10.17.2 Zhongyianke Biotech Human Vaccine Product Overview
10.17.3 Zhongyianke Biotech Human Vaccine Product Market Performance
10.17.4 Zhongyianke Biotech Business Overview
10.17.5 Zhongyianke Biotech Recent Developments
10.18 Bharat Biotech
10.18.1 Bharat Biotech Human Vaccine Basic Information
10.18.2 Bharat Biotech Human Vaccine Product Overview
10.18.3 Bharat Biotech Human Vaccine Product Market Performance
10.18.4 Bharat Biotech Business Overview
10.18.5 Bharat Biotech Recent Developments
10.19 Bavarian Nordic
10.19.1 Bavarian Nordic Human Vaccine Basic Information
10.19.2 Bavarian Nordic Human Vaccine Product Overview
10.19.3 Bavarian Nordic Human Vaccine Product Market Performance
10.19.4 Bavarian Nordic Business Overview
10.19.5 Bavarian Nordic Recent Developments
10.20 Sanofi-Pasteur
10.20.1 Sanofi-Pasteur Human Vaccine Basic Information
10.20.2 Sanofi-Pasteur Human Vaccine Product Overview
10.20.3 Sanofi-Pasteur Human Vaccine Product Market Performance
10.20.4 Sanofi-Pasteur Business Overview
10.20.5 Sanofi-Pasteur Recent Developments
10.21 Indian Immunologicals
10.21.1 Indian Immunologicals Human Vaccine Basic Information
10.21.2 Indian Immunologicals Human Vaccine Product Overview
10.21.3 Indian Immunologicals Human Vaccine Product Market Performance
10.21.4 Indian Immunologicals Business Overview
10.21.5 Indian Immunologicals Recent Developments
10.22 KANGH
10.22.1 KANGH Human Vaccine Basic Information
10.22.2 KANGH Human Vaccine Product Overview
10.22.3 KANGH Human Vaccine Product Market Performance
10.22.4 KANGH Business Overview
10.22.5 KANGH Recent Developments
10.23 Henan Grand Biopharma
10.23.1 Henan Grand Biopharma Human Vaccine Basic Information
10.23.2 Henan Grand Biopharma Human Vaccine Product Overview
10.23.3 Henan Grand Biopharma Human Vaccine Product Market Performance
10.23.4 Henan Grand Biopharma Business Overview
10.23.5 Henan Grand Biopharma Recent Developments
10.24 ZhongKe Biopharm
10.24.1 ZhongKe Biopharm Human Vaccine Basic Information
10.24.2 ZhongKe Biopharm Human Vaccine Product Overview
10.24.3 ZhongKe Biopharm Human Vaccine Product Market Performance
10.24.4 ZhongKe Biopharm Business Overview
10.24.5 ZhongKe Biopharm Recent Developments
10.25 Zhuoyi Biological
10.25.1 Zhuoyi Biological Human Vaccine Basic Information
10.25.2 Zhuoyi Biological Human Vaccine Product Overview
10.25.3 Zhuoyi Biological Human Vaccine Product Market Performance
10.25.4 Zhuoyi Biological Business Overview
10.25.5 Zhuoyi Biological Recent Developments
11 HUMAN VACCINE MARKET FORECAST BY REGION
11.1 Global Human Vaccine Market Size Forecast
11.2 Global Human Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Human Vaccine Market Size Forecast by Region
11.2.4 South America Human Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Human Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Vaccine by Type (2025-2032)
12.1.2 Global Human Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Vaccine by Type (2025-2032)
12.2 Global Human Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Human Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Human Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Human Vaccine
1.2 Key Market Segments
1.2.1 Human Vaccine Segment by Type
1.2.2 Human Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HUMAN VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Human Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HUMAN VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Human Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Human Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Vaccine Sales Sites, Area Served, Product Type
3.6 Human Vaccine Market Competitive Situation and Trends
3.6.1 Human Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HUMAN VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Human Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HUMAN VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 HUMAN VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Human Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Human Vaccine Price by Type (2019-2024)
7 HUMAN VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Vaccine Market Sales by Application (2019-2024)
7.3 Global Human Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Human Vaccine Sales Growth Rate by Application (2019-2024)
8 HUMAN VACCINE MARKET CONSUMPTION BY REGION
8.1 Global Human Vaccine Sales by Region
8.1.1 Global Human Vaccine Sales by Region
8.1.2 Global Human Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Human Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 HUMAN VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Human Vaccine by Region (2019-2024)
9.2 Global Human Vaccine Revenue Market Share by Region (2019-2024)
9.3 Global Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Human Vaccine Production
9.4.1 North America Human Vaccine Production Growth Rate (2019-2024)
9.4.2 North America Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Human Vaccine Production
9.5.1 Europe Human Vaccine Production Growth Rate (2019-2024)
9.5.2 Europe Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Human Vaccine Production (2019-2024)
9.6.1 Japan Human Vaccine Production Growth Rate (2019-2024)
9.6.2 Japan Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Human Vaccine Production (2019-2024)
9.7.1 China Human Vaccine Production Growth Rate (2019-2024)
9.7.2 China Human Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 CNBG
10.1.1 CNBG Human Vaccine Basic Information
10.1.2 CNBG Human Vaccine Product Overview
10.1.3 CNBG Human Vaccine Product Market Performance
10.1.4 CNBG Business Overview
10.1.5 CNBG Human Vaccine SWOT Analysis
10.1.6 CNBG Recent Developments
10.2 Changsheng Life
10.2.1 Changsheng Life Human Vaccine Basic Information
10.2.2 Changsheng Life Human Vaccine Product Overview
10.2.3 Changsheng Life Human Vaccine Product Market Performance
10.2.4 Changsheng Life Business Overview
10.2.5 Changsheng Life Human Vaccine SWOT Analysis
10.2.6 Changsheng Life Recent Developments
10.3 Zhifei
10.3.1 Zhifei Human Vaccine Basic Information
10.3.2 Zhifei Human Vaccine Product Overview
10.3.3 Zhifei Human Vaccine Product Market Performance
10.3.4 Zhifei Human Vaccine SWOT Analysis
10.3.5 Zhifei Business Overview
10.3.6 Zhifei Recent Developments
10.4 ChengDa Bio
10.4.1 ChengDa Bio Human Vaccine Basic Information
10.4.2 ChengDa Bio Human Vaccine Product Overview
10.4.3 ChengDa Bio Human Vaccine Product Market Performance
10.4.4 ChengDa Bio Business Overview
10.4.5 ChengDa Bio Recent Developments
10.5 Kangtai
10.5.1 Kangtai Human Vaccine Basic Information
10.5.2 Kangtai Human Vaccine Product Overview
10.5.3 Kangtai Human Vaccine Product Market Performance
10.5.4 Kangtai Business Overview
10.5.5 Kangtai Recent Developments
10.6 SINOVAC BIOTECH
10.6.1 SINOVAC BIOTECH Human Vaccine Basic Information
10.6.2 SINOVAC BIOTECH Human Vaccine Product Overview
10.6.3 SINOVAC BIOTECH Human Vaccine Product Market Performance
10.6.4 SINOVAC BIOTECH Business Overview
10.6.5 SINOVAC BIOTECH Recent Developments
10.7 Hissen
10.7.1 Hissen Human Vaccine Basic Information
10.7.2 Hissen Human Vaccine Product Overview
10.7.3 Hissen Human Vaccine Product Market Performance
10.7.4 Hissen Business Overview
10.7.5 Hissen Recent Developments
10.8 Walvax Biotechnology
10.8.1 Walvax Biotechnology Human Vaccine Basic Information
10.8.2 Walvax Biotechnology Human Vaccine Product Overview
10.8.3 Walvax Biotechnology Human Vaccine Product Market Performance
10.8.4 Walvax Biotechnology Business Overview
10.8.5 Walvax Biotechnology Recent Developments
10.9 GSK
10.9.1 GSK Human Vaccine Basic Information
10.9.2 GSK Human Vaccine Product Overview
10.9.3 GSK Human Vaccine Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 SANOFI
10.10.1 SANOFI Human Vaccine Basic Information
10.10.2 SANOFI Human Vaccine Product Overview
10.10.3 SANOFI Human Vaccine Product Market Performance
10.10.4 SANOFI Business Overview
10.10.5 SANOFI Recent Developments
10.11 Rong An
10.11.1 Rong An Human Vaccine Basic Information
10.11.2 Rong An Human Vaccine Product Overview
10.11.3 Rong An Human Vaccine Product Market Performance
10.11.4 Rong An Business Overview
10.11.5 Rong An Recent Developments
10.12 NuoCheng Bio
10.12.1 NuoCheng Bio Human Vaccine Basic Information
10.12.2 NuoCheng Bio Human Vaccine Product Overview
10.12.3 NuoCheng Bio Human Vaccine Product Market Performance
10.12.4 NuoCheng Bio Business Overview
10.12.5 NuoCheng Bio Recent Developments
10.13 Hualan Bio
10.13.1 Hualan Bio Human Vaccine Basic Information
10.13.2 Hualan Bio Human Vaccine Product Overview
10.13.3 Hualan Bio Human Vaccine Product Market Performance
10.13.4 Hualan Bio Business Overview
10.13.5 Hualan Bio Recent Developments
10.14 Tiantan biological
10.14.1 Tiantan biological Human Vaccine Basic Information
10.14.2 Tiantan biological Human Vaccine Product Overview
10.14.3 Tiantan biological Human Vaccine Product Market Performance
10.14.4 Tiantan biological Business Overview
10.14.5 Tiantan biological Recent Developments
10.15 Changchun Baike
10.15.1 Changchun Baike Human Vaccine Basic Information
10.15.2 Changchun Baike Human Vaccine Product Overview
10.15.3 Changchun Baike Human Vaccine Product Market Performance
10.15.4 Changchun Baike Business Overview
10.15.5 Changchun Baike Recent Developments
10.16 Adimmune
10.16.1 Adimmune Human Vaccine Basic Information
10.16.2 Adimmune Human Vaccine Product Overview
10.16.3 Adimmune Human Vaccine Product Market Performance
10.16.4 Adimmune Business Overview
10.16.5 Adimmune Recent Developments
10.17 Zhongyianke Biotech
10.17.1 Zhongyianke Biotech Human Vaccine Basic Information
10.17.2 Zhongyianke Biotech Human Vaccine Product Overview
10.17.3 Zhongyianke Biotech Human Vaccine Product Market Performance
10.17.4 Zhongyianke Biotech Business Overview
10.17.5 Zhongyianke Biotech Recent Developments
10.18 Bharat Biotech
10.18.1 Bharat Biotech Human Vaccine Basic Information
10.18.2 Bharat Biotech Human Vaccine Product Overview
10.18.3 Bharat Biotech Human Vaccine Product Market Performance
10.18.4 Bharat Biotech Business Overview
10.18.5 Bharat Biotech Recent Developments
10.19 Bavarian Nordic
10.19.1 Bavarian Nordic Human Vaccine Basic Information
10.19.2 Bavarian Nordic Human Vaccine Product Overview
10.19.3 Bavarian Nordic Human Vaccine Product Market Performance
10.19.4 Bavarian Nordic Business Overview
10.19.5 Bavarian Nordic Recent Developments
10.20 Sanofi-Pasteur
10.20.1 Sanofi-Pasteur Human Vaccine Basic Information
10.20.2 Sanofi-Pasteur Human Vaccine Product Overview
10.20.3 Sanofi-Pasteur Human Vaccine Product Market Performance
10.20.4 Sanofi-Pasteur Business Overview
10.20.5 Sanofi-Pasteur Recent Developments
10.21 Indian Immunologicals
10.21.1 Indian Immunologicals Human Vaccine Basic Information
10.21.2 Indian Immunologicals Human Vaccine Product Overview
10.21.3 Indian Immunologicals Human Vaccine Product Market Performance
10.21.4 Indian Immunologicals Business Overview
10.21.5 Indian Immunologicals Recent Developments
10.22 KANGH
10.22.1 KANGH Human Vaccine Basic Information
10.22.2 KANGH Human Vaccine Product Overview
10.22.3 KANGH Human Vaccine Product Market Performance
10.22.4 KANGH Business Overview
10.22.5 KANGH Recent Developments
10.23 Henan Grand Biopharma
10.23.1 Henan Grand Biopharma Human Vaccine Basic Information
10.23.2 Henan Grand Biopharma Human Vaccine Product Overview
10.23.3 Henan Grand Biopharma Human Vaccine Product Market Performance
10.23.4 Henan Grand Biopharma Business Overview
10.23.5 Henan Grand Biopharma Recent Developments
10.24 ZhongKe Biopharm
10.24.1 ZhongKe Biopharm Human Vaccine Basic Information
10.24.2 ZhongKe Biopharm Human Vaccine Product Overview
10.24.3 ZhongKe Biopharm Human Vaccine Product Market Performance
10.24.4 ZhongKe Biopharm Business Overview
10.24.5 ZhongKe Biopharm Recent Developments
10.25 Zhuoyi Biological
10.25.1 Zhuoyi Biological Human Vaccine Basic Information
10.25.2 Zhuoyi Biological Human Vaccine Product Overview
10.25.3 Zhuoyi Biological Human Vaccine Product Market Performance
10.25.4 Zhuoyi Biological Business Overview
10.25.5 Zhuoyi Biological Recent Developments
11 HUMAN VACCINE MARKET FORECAST BY REGION
11.1 Global Human Vaccine Market Size Forecast
11.2 Global Human Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Human Vaccine Market Size Forecast by Region
11.2.4 South America Human Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Human Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Vaccine by Type (2025-2032)
12.1.2 Global Human Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Vaccine by Type (2025-2032)
12.2 Global Human Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Human Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Human Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Vaccine Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Human Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2022)
Table 10. Global Market Human Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Vaccine Product Type
Table 13. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Vaccine Market Challenges
Table 22. Global Human Vaccine Sales by Type (K MT)
Table 23. Global Human Vaccine Market Size by Type (M USD)
Table 24. Global Human Vaccine Sales (K MT) by Type (2019-2024)
Table 25. Global Human Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Human Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Human Vaccine Price (USD/MT) by Type (2019-2024)
Table 29. Global Human Vaccine Sales (K MT) by Application
Table 30. Global Human Vaccine Market Size by Application
Table 31. Global Human Vaccine Sales by Application (2019-2024) & (K MT)
Table 32. Global Human Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Human Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Vaccine Market Share by Application (2019-2024)
Table 35. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Vaccine Sales by Region (2019-2024) & (K MT)
Table 37. Global Human Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Human Vaccine Sales by Country (2019-2024) & (K MT)
Table 39. Europe Human Vaccine Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Human Vaccine Sales by Region (2019-2024) & (K MT)
Table 41. South America Human Vaccine Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Human Vaccine Sales by Region (2019-2024) & (K MT)
Table 43. Global Human Vaccine Production (K MT) by Region (2019-2024)
Table 44. Global Human Vaccine Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Human Vaccine Revenue Market Share by Region (2019-2024)
Table 46. Global Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. CNBG Human Vaccine Basic Information
Table 52. CNBG Human Vaccine Product Overview
Table 53. CNBG Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. CNBG Business Overview
Table 55. CNBG Human Vaccine SWOT Analysis
Table 56. CNBG Recent Developments
Table 57. Changsheng Life Human Vaccine Basic Information
Table 58. Changsheng Life Human Vaccine Product Overview
Table 59. Changsheng Life Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Changsheng Life Business Overview
Table 61. Changsheng Life Human Vaccine SWOT Analysis
Table 62. Changsheng Life Recent Developments
Table 63. Zhifei Human Vaccine Basic Information
Table 64. Zhifei Human Vaccine Product Overview
Table 65. Zhifei Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Zhifei Human Vaccine SWOT Analysis
Table 67. Zhifei Business Overview
Table 68. Zhifei Recent Developments
Table 69. ChengDa Bio Human Vaccine Basic Information
Table 70. ChengDa Bio Human Vaccine Product Overview
Table 71. ChengDa Bio Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. ChengDa Bio Business Overview
Table 73. ChengDa Bio Recent Developments
Table 74. Kangtai Human Vaccine Basic Information
Table 75. Kangtai Human Vaccine Product Overview
Table 76. Kangtai Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Kangtai Business Overview
Table 78. Kangtai Recent Developments
Table 79. SINOVAC BIOTECH Human Vaccine Basic Information
Table 80. SINOVAC BIOTECH Human Vaccine Product Overview
Table 81. SINOVAC BIOTECH Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. SINOVAC BIOTECH Business Overview
Table 83. SINOVAC BIOTECH Recent Developments
Table 84. Hissen Human Vaccine Basic Information
Table 85. Hissen Human Vaccine Product Overview
Table 86. Hissen Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Hissen Business Overview
Table 88. Hissen Recent Developments
Table 89. Walvax Biotechnology Human Vaccine Basic Information
Table 90. Walvax Biotechnology Human Vaccine Product Overview
Table 91. Walvax Biotechnology Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Walvax Biotechnology Business Overview
Table 93. Walvax Biotechnology Recent Developments
Table 94. GSK Human Vaccine Basic Information
Table 95. GSK Human Vaccine Product Overview
Table 96. GSK Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. GSK Business Overview
Table 98. GSK Recent Developments
Table 99. SANOFI Human Vaccine Basic Information
Table 100. SANOFI Human Vaccine Product Overview
Table 101. SANOFI Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. SANOFI Business Overview
Table 103. SANOFI Recent Developments
Table 104. Rong An Human Vaccine Basic Information
Table 105. Rong An Human Vaccine Product Overview
Table 106. Rong An Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Rong An Business Overview
Table 108. Rong An Recent Developments
Table 109. NuoCheng Bio Human Vaccine Basic Information
Table 110. NuoCheng Bio Human Vaccine Product Overview
Table 111. NuoCheng Bio Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. NuoCheng Bio Business Overview
Table 113. NuoCheng Bio Recent Developments
Table 114. Hualan Bio Human Vaccine Basic Information
Table 115. Hualan Bio Human Vaccine Product Overview
Table 116. Hualan Bio Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Hualan Bio Business Overview
Table 118. Hualan Bio Recent Developments
Table 119. Tiantan biological Human Vaccine Basic Information
Table 120. Tiantan biological Human Vaccine Product Overview
Table 121. Tiantan biological Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Tiantan biological Business Overview
Table 123. Tiantan biological Recent Developments
Table 124. Changchun Baike Human Vaccine Basic Information
Table 125. Changchun Baike Human Vaccine Product Overview
Table 126. Changchun Baike Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Changchun Baike Business Overview
Table 128. Changchun Baike Recent Developments
Table 129. Adimmune Human Vaccine Basic Information
Table 130. Adimmune Human Vaccine Product Overview
Table 131. Adimmune Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Adimmune Business Overview
Table 133. Adimmune Recent Developments
Table 134. Zhongyianke Biotech Human Vaccine Basic Information
Table 135. Zhongyianke Biotech Human Vaccine Product Overview
Table 136. Zhongyianke Biotech Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Zhongyianke Biotech Business Overview
Table 138. Zhongyianke Biotech Recent Developments
Table 139. Bharat Biotech Human Vaccine Basic Information
Table 140. Bharat Biotech Human Vaccine Product Overview
Table 141. Bharat Biotech Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Bharat Biotech Business Overview
Table 143. Bharat Biotech Recent Developments
Table 144. Bavarian Nordic Human Vaccine Basic Information
Table 145. Bavarian Nordic Human Vaccine Product Overview
Table 146. Bavarian Nordic Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Bavarian Nordic Business Overview
Table 148. Bavarian Nordic Recent Developments
Table 149. Sanofi-Pasteur Human Vaccine Basic Information
Table 150. Sanofi-Pasteur Human Vaccine Product Overview
Table 151. Sanofi-Pasteur Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Sanofi-Pasteur Business Overview
Table 153. Sanofi-Pasteur Recent Developments
Table 154. Indian Immunologicals Human Vaccine Basic Information
Table 155. Indian Immunologicals Human Vaccine Product Overview
Table 156. Indian Immunologicals Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. Indian Immunologicals Business Overview
Table 158. Indian Immunologicals Recent Developments
Table 159. KANGH Human Vaccine Basic Information
Table 160. KANGH Human Vaccine Product Overview
Table 161. KANGH Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 162. KANGH Business Overview
Table 163. KANGH Recent Developments
Table 164. Henan Grand Biopharma Human Vaccine Basic Information
Table 165. Henan Grand Biopharma Human Vaccine Product Overview
Table 166. Henan Grand Biopharma Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 167. Henan Grand Biopharma Business Overview
Table 168. Henan Grand Biopharma Recent Developments
Table 169. ZhongKe Biopharm Human Vaccine Basic Information
Table 170. ZhongKe Biopharm Human Vaccine Product Overview
Table 171. ZhongKe Biopharm Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 172. ZhongKe Biopharm Business Overview
Table 173. ZhongKe Biopharm Recent Developments
Table 174. Zhuoyi Biological Human Vaccine Basic Information
Table 175. Zhuoyi Biological Human Vaccine Product Overview
Table 176. Zhuoyi Biological Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 177. Zhuoyi Biological Business Overview
Table 178. Zhuoyi Biological Recent Developments
Table 179. Global Human Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 180. Global Human Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 181. North America Human Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 182. North America Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 183. Europe Human Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 184. Europe Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 185. Asia Pacific Human Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 186. Asia Pacific Human Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 187. South America Human Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 188. South America Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 189. Middle East and Africa Human Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 190. Middle East and Africa Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 191. Global Human Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 192. Global Human Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 193. Global Human Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 194. Global Human Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 195. Global Human Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Human Vaccine Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Human Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccine as of 2022)
Table 10. Global Market Human Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Vaccine Sales Sites and Area Served
Table 12. Manufacturers Human Vaccine Product Type
Table 13. Global Human Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Vaccine Market Challenges
Table 22. Global Human Vaccine Sales by Type (K MT)
Table 23. Global Human Vaccine Market Size by Type (M USD)
Table 24. Global Human Vaccine Sales (K MT) by Type (2019-2024)
Table 25. Global Human Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Human Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Human Vaccine Price (USD/MT) by Type (2019-2024)
Table 29. Global Human Vaccine Sales (K MT) by Application
Table 30. Global Human Vaccine Market Size by Application
Table 31. Global Human Vaccine Sales by Application (2019-2024) & (K MT)
Table 32. Global Human Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Human Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Vaccine Market Share by Application (2019-2024)
Table 35. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Vaccine Sales by Region (2019-2024) & (K MT)
Table 37. Global Human Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Human Vaccine Sales by Country (2019-2024) & (K MT)
Table 39. Europe Human Vaccine Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Human Vaccine Sales by Region (2019-2024) & (K MT)
Table 41. South America Human Vaccine Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Human Vaccine Sales by Region (2019-2024) & (K MT)
Table 43. Global Human Vaccine Production (K MT) by Region (2019-2024)
Table 44. Global Human Vaccine Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Human Vaccine Revenue Market Share by Region (2019-2024)
Table 46. Global Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Human Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. CNBG Human Vaccine Basic Information
Table 52. CNBG Human Vaccine Product Overview
Table 53. CNBG Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. CNBG Business Overview
Table 55. CNBG Human Vaccine SWOT Analysis
Table 56. CNBG Recent Developments
Table 57. Changsheng Life Human Vaccine Basic Information
Table 58. Changsheng Life Human Vaccine Product Overview
Table 59. Changsheng Life Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Changsheng Life Business Overview
Table 61. Changsheng Life Human Vaccine SWOT Analysis
Table 62. Changsheng Life Recent Developments
Table 63. Zhifei Human Vaccine Basic Information
Table 64. Zhifei Human Vaccine Product Overview
Table 65. Zhifei Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Zhifei Human Vaccine SWOT Analysis
Table 67. Zhifei Business Overview
Table 68. Zhifei Recent Developments
Table 69. ChengDa Bio Human Vaccine Basic Information
Table 70. ChengDa Bio Human Vaccine Product Overview
Table 71. ChengDa Bio Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. ChengDa Bio Business Overview
Table 73. ChengDa Bio Recent Developments
Table 74. Kangtai Human Vaccine Basic Information
Table 75. Kangtai Human Vaccine Product Overview
Table 76. Kangtai Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Kangtai Business Overview
Table 78. Kangtai Recent Developments
Table 79. SINOVAC BIOTECH Human Vaccine Basic Information
Table 80. SINOVAC BIOTECH Human Vaccine Product Overview
Table 81. SINOVAC BIOTECH Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. SINOVAC BIOTECH Business Overview
Table 83. SINOVAC BIOTECH Recent Developments
Table 84. Hissen Human Vaccine Basic Information
Table 85. Hissen Human Vaccine Product Overview
Table 86. Hissen Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Hissen Business Overview
Table 88. Hissen Recent Developments
Table 89. Walvax Biotechnology Human Vaccine Basic Information
Table 90. Walvax Biotechnology Human Vaccine Product Overview
Table 91. Walvax Biotechnology Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Walvax Biotechnology Business Overview
Table 93. Walvax Biotechnology Recent Developments
Table 94. GSK Human Vaccine Basic Information
Table 95. GSK Human Vaccine Product Overview
Table 96. GSK Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. GSK Business Overview
Table 98. GSK Recent Developments
Table 99. SANOFI Human Vaccine Basic Information
Table 100. SANOFI Human Vaccine Product Overview
Table 101. SANOFI Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. SANOFI Business Overview
Table 103. SANOFI Recent Developments
Table 104. Rong An Human Vaccine Basic Information
Table 105. Rong An Human Vaccine Product Overview
Table 106. Rong An Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Rong An Business Overview
Table 108. Rong An Recent Developments
Table 109. NuoCheng Bio Human Vaccine Basic Information
Table 110. NuoCheng Bio Human Vaccine Product Overview
Table 111. NuoCheng Bio Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. NuoCheng Bio Business Overview
Table 113. NuoCheng Bio Recent Developments
Table 114. Hualan Bio Human Vaccine Basic Information
Table 115. Hualan Bio Human Vaccine Product Overview
Table 116. Hualan Bio Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Hualan Bio Business Overview
Table 118. Hualan Bio Recent Developments
Table 119. Tiantan biological Human Vaccine Basic Information
Table 120. Tiantan biological Human Vaccine Product Overview
Table 121. Tiantan biological Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Tiantan biological Business Overview
Table 123. Tiantan biological Recent Developments
Table 124. Changchun Baike Human Vaccine Basic Information
Table 125. Changchun Baike Human Vaccine Product Overview
Table 126. Changchun Baike Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Changchun Baike Business Overview
Table 128. Changchun Baike Recent Developments
Table 129. Adimmune Human Vaccine Basic Information
Table 130. Adimmune Human Vaccine Product Overview
Table 131. Adimmune Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 132. Adimmune Business Overview
Table 133. Adimmune Recent Developments
Table 134. Zhongyianke Biotech Human Vaccine Basic Information
Table 135. Zhongyianke Biotech Human Vaccine Product Overview
Table 136. Zhongyianke Biotech Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 137. Zhongyianke Biotech Business Overview
Table 138. Zhongyianke Biotech Recent Developments
Table 139. Bharat Biotech Human Vaccine Basic Information
Table 140. Bharat Biotech Human Vaccine Product Overview
Table 141. Bharat Biotech Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 142. Bharat Biotech Business Overview
Table 143. Bharat Biotech Recent Developments
Table 144. Bavarian Nordic Human Vaccine Basic Information
Table 145. Bavarian Nordic Human Vaccine Product Overview
Table 146. Bavarian Nordic Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 147. Bavarian Nordic Business Overview
Table 148. Bavarian Nordic Recent Developments
Table 149. Sanofi-Pasteur Human Vaccine Basic Information
Table 150. Sanofi-Pasteur Human Vaccine Product Overview
Table 151. Sanofi-Pasteur Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 152. Sanofi-Pasteur Business Overview
Table 153. Sanofi-Pasteur Recent Developments
Table 154. Indian Immunologicals Human Vaccine Basic Information
Table 155. Indian Immunologicals Human Vaccine Product Overview
Table 156. Indian Immunologicals Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 157. Indian Immunologicals Business Overview
Table 158. Indian Immunologicals Recent Developments
Table 159. KANGH Human Vaccine Basic Information
Table 160. KANGH Human Vaccine Product Overview
Table 161. KANGH Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 162. KANGH Business Overview
Table 163. KANGH Recent Developments
Table 164. Henan Grand Biopharma Human Vaccine Basic Information
Table 165. Henan Grand Biopharma Human Vaccine Product Overview
Table 166. Henan Grand Biopharma Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 167. Henan Grand Biopharma Business Overview
Table 168. Henan Grand Biopharma Recent Developments
Table 169. ZhongKe Biopharm Human Vaccine Basic Information
Table 170. ZhongKe Biopharm Human Vaccine Product Overview
Table 171. ZhongKe Biopharm Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 172. ZhongKe Biopharm Business Overview
Table 173. ZhongKe Biopharm Recent Developments
Table 174. Zhuoyi Biological Human Vaccine Basic Information
Table 175. Zhuoyi Biological Human Vaccine Product Overview
Table 176. Zhuoyi Biological Human Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 177. Zhuoyi Biological Business Overview
Table 178. Zhuoyi Biological Recent Developments
Table 179. Global Human Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 180. Global Human Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 181. North America Human Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 182. North America Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 183. Europe Human Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 184. Europe Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 185. Asia Pacific Human Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 186. Asia Pacific Human Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 187. South America Human Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 188. South America Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 189. Middle East and Africa Human Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 190. Middle East and Africa Human Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 191. Global Human Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 192. Global Human Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 193. Global Human Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 194. Global Human Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 195. Global Human Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Human Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Human Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Human Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Vaccine Market Size by Country (M USD)
Figure 11. Human Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Human Vaccine by Type in 2023
Figure 20. Market Size Share of Human Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Human Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Vaccine Market Share by Application
Figure 24. Global Human Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Human Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Vaccine Market Share by Application (2019-2024)
Figure 27. Global Human Vaccine Market Share by Application in 2023
Figure 28. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Human Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Human Vaccine Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Human Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Human Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Human Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Human Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Human Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Human Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Human Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Human Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Human Vaccine Production Market Share by Region (2019-2024)
Figure 62. North America Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 65. China Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Human Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Human Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Human Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Human Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Human Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Human Vaccine Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Human Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Human Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Human Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Vaccine Market Size by Country (M USD)
Figure 11. Human Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Human Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Human Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Vaccine Market Share by Type
Figure 18. Sales Market Share of Human Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Human Vaccine by Type in 2023
Figure 20. Market Size Share of Human Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Human Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Vaccine Market Share by Application
Figure 24. Global Human Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Human Vaccine Sales Market Share by Application in 2023
Figure 26. Global Human Vaccine Market Share by Application (2019-2024)
Figure 27. Global Human Vaccine Market Share by Application in 2023
Figure 28. Global Human Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Human Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Human Vaccine Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Human Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Human Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Human Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Human Vaccine Sales Market Share by Region in 2023
Figure 44. China Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Human Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Human Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Human Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Human Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Human Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Human Vaccine Production Market Share by Region (2019-2024)
Figure 62. North America Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 65. China Human Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Human Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Human Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Human Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Human Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Human Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Human Vaccine Market Share Forecast by Application (2025-2032)
